Marksans Pharma Limited
Share Price Target & Analysis

NSE:MARKSANS

289.03

VWAP

292

Open

294.45

Close

295.35

High

282.7

Low

350.95

52 Week High

286.90 ⇩
-7.55 (-2.56%)

MARKSANS

(PHARMA)
67.3% Momentum

Sideways to Positive

155

52 Week Low

7.4

EPS

40.41

PE

7.55

PB

Economical
Quality

Gold
Valuation

#Analysis

NSE: MARKSANS Share Price Financial Analysis & Valuation

Marksans Pharma Limited (MARKSANS) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Small Cap company with Market Capitalization of Rs 2308.5 (in Cr). Total number of free float shares are 40.9 (in Lacs). Marksans Pharma Limited is listed on NSE with Exchange ID - INE750C01026 and trading code is NSE:MARKSANS with short name Marksans Pharma.

In the past 1 year, Marksans Pharma Limited has declared an equity dividend of Rs 0.31 per share. At the current share price of MARKSANS at Rs 286.90, this results in a dividend yield of 0.11 %.

As per the Fundamental Analysis of NSE:MARKSANS, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine MARKSANS underlying value and future prospects. All of this data is available in MARKSANS financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:MARKSANS, it is clearly understood that MARKSANS is Economical performer in terms of earnings and profit margins with an EPS of 7.4. NSE:MARKSANS book value per share as of today is 37.99. The current price to book ratio for MARKSANS as of Oct 23, 2026 is 7.55.

Valuation of the Stock: The current valuation of MARKSANS stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of MARKSANS whether to BUY this stock at current valuation. The delivery percentage of MARKSANS is 349858% is very crucial parameter which shows that 349858% investors are anticipating that the price of MARKSANS share should go up with VWAP at 289.03.

Now, the main question is whether to BUY or SELL, NSE:MARKSANS at current valuation.
As per latest Analysis No. #2993:-

⇑ STRONG BUY MARKSANS if All Greens

⇗ BUY MARKSANS (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD MARKSANS (With Stop Loss) if only 1 Green

⇘ SELL MARKSANS if NO Green Indicator

NSE: MARKSANS Share Price Today (Oct 23, 2026)

(Marksans Pharma Limited Daily Analysis on the basis of MARKSANS Intraday Graph & Trend)

Marksans Pharma Limited share price moved Down by -2.56% from its previous close of Rs 294.45. MARKSANS stock last traded price is 286.90. MARKSANS share price trend is Down with a total of 1414460 stocks traded till now. It has touched an intraday high of Rs 295.35 and an intraday low of Rs 282.7. The MARKSANS trading at 286.90, Down by Rs. -7.55, or -2.56 percent which suggests that most of the Traders are anticipating that the price of MARKSANS share should go Down.

NSE: MARKSANS Share Price Tomorrow Prediction

(Marksans Pharma Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of MARKSANS)

Marksans Pharma Limited share price moved Down by -2.56%. MARKSANS share price short term trend is Down. It suggests that MARKSANS Share Price for Tomorrow remains the same with VWAP at 289.03 will be treated as stop loss for intraday traders. Marksans Pharma Limited Long term investors can follow the MARKSANS long term trend as mentiond in future forecast table.

NSE Code

NSE: MARKSANS

MARKSANS Share Price Today

 286.90

MARKSANS Share Price Target Prediction for 2026 ^

 243.5 - 352.7

MARKSANS Share Price Target Prediction for 2027*^

 352.7 - 375.7

MARKSANS Share Price Target Prediction for 2028*^

 375.7 - 402

MARKSANS Share Price Target Prediction for 2029*^

 422

MARKSANS Share Price Target Prediction for 2030*^

 434

MARKSANS Share Price Target Prediction for 2035*^

 473
MARKSANS Current Book Value
37.8

*Marksans Pharma Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^MARKSANS share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

MARKSANS Technical Analysis

Candlestick Pattern: @330.15

MARKSANS Moving Averages

BUY (12) NEUTRAL (0) SELL (2)
MA Simple Action S1 Expo Action E2
MA_5 332.01 SELL 331.52 SELL
MA_12 328.14 BUY 326.79 BUY
MA_20 326.47 BUY 320.53 BUY
MA_32 302.35 BUY 308.02 BUY
MA_50 290.37 BUY 295.55 BUY
MA_100 266.62 BUY 271.83 BUY
MA_200 217.45 BUY 240.84 BUY

MARKSANS Trend Oscillators

BUY (3) NEUTRAL (0) SELL (1)
Trend Oscillators Value Action
Bollinger Bands 326.47 Uptrend
MACD -1.42 SELL
ADX 40.41 Strong Trend
DMI (+/-) 28.23 / 12.74 Uptrend

MARKSANS Momentum Oscillators

BUY (4) NEUTRAL (7) SELL (1)
Momentum Oscillators Value Action
RSI 60.7 Neutral
STOCHASTIC_K (Fast) 33.64 Neutral
STOCHASTIC_D (Slow) 54.74 Neutral
CCI 71.08 Neutral
PSAR 313.84 BUY
TRUE RANGE 11.35 BUY
ATR 13.35 BUY
WILLIAMS R -53.73 Neutral
TRIX 0 Neutral
STOCHASTIC RSI K 0 Oversold
STOCHASTIC RSI D 58.12 Neutral
MOMENTUM 51.2 BUY

MARKSANS Last 1 Year Trend

Duration Value
1 Year 92.42%
3 Months 30.62%
1 Month 18.35%
1 Week -0.71%

MARKSANS Technical Analysis Summary

Updated on 2026-09-09
Action Overall (%)
BUY 63%
NEUTRAL / HOLD 23%
SELL 13%

(powered by Zerodha)

Most popular Questions & Answers about MARKSANS

Marksans Pharma Limited Frequently Asked Questions (FAQs)

Marksans Pharma Limited stock last traded price is 286.90. MARKSANS share price moved Down by -2.56% from its previous close of Rs 294.45.

Marksans Pharma Limited share price trend is Down with a total of 1414460 stocks traded till now. It has touched an intraday high of Rs 354.4595 and an intraday low of Rs 282.7. The MARKSANS trading at 286.90, Down by Rs. -7.55, or -2.56 percent which suggests that most of the Traders are anticipating that the price of MARKSANS share should go Down and the Stop Loss will be around 289.03.

The market cap of Marksans Pharma Limited is ₹2308.5 (in Cr) as of Oct 22, 2026.

The current price to earning ratio for Marksans Pharma Limited as of Oct 22, 2026 is 40.41.

The current price to book ratio for Marksans Pharma Limited as of Oct 22, 2026 is 7.55.

The highest price of Marksans Pharma Limited stock is ₹350.95 in the last 52-week.

The lowest price of Marksans Pharma Limited stock is ₹155 in the last 52-week.

Marksans Pharma Limited share trading at ₹286.90, Down by Rs. -7.55, or -2.56 percent which suggests that most of the traders are anticipating that the price of MARKSANS share should go Down.

In 2026, Stock price target for Marksans Pharma Limited (MARKSANS) will be around ₹243.5 on downside and ₹352.7 on upside. Marksans Pharma Limited share price target is based on current financial year earings of the company.

In 2027, Stock price target for Marksans Pharma Limited (MARKSANS) will be around ₹352.7 on downside and ₹375.7 on upside. Marksans Pharma Limited share price target is based on forecasted future earnings of the company.

In 2028, Stock price target for Marksans Pharma Limited (MARKSANS) will be around ₹375.7 on downside and ₹402 on upside. Marksans Pharma Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Marksans Pharma Limited (MARKSANS) will be around ₹434 Marksans Pharma Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of MARKSANS.

The price of Marksans Pharma Limited (MARKSANS) shares moved by -2.56%. The short-term trend for MARKSANS share price is Down. It implies that the share price of MARKSANS will stay the same tomorrow and that intraday traders should treat VWAP at 289.03 as a stop loss. Investors with a long-term outlook can track MARKSANS long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of MARKSANS stock is 88.7. Compared to the current market price of 286.90 INR, the MARKSANS stock is Overvalued by 69.1%.

As per the fundamental analysis of Marksans Pharma Limited (MARKSANS), it is of Economical quality in terms of earnings and profit margins with an EPS of 7.4. Marksans Pharma Limited book value per share as of today is 37.99. The current price to book ratio for MARKSANS as of Oct 23, 2026 is 7.55.


NSE:MARKSANS News & Other Useful Information about MARKSANS Share Price


Peer Comparison of NSE: MARKSANS

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1748.00 16.35 97.89
DIVISLAB 8950.00 115.55 663.06
MEDICAMEQ 253.35 12.15 208.08
CIPLA 1338.00 51.67 434.02
DRREDDY 1229.50 53.19 380.63
TORNTPHARM 4524.40 87.32 235.7
BIOCON 323.50 1.27 166.51
LUPIN 1928.90 154.86 718.33
ALKEM 4947.00 212.33 1218.48
AUROPHARMA 1571.70 46.49 403.84
ABBOTINDIA 25030.00 766.11 2448.41
GLAXO 2404.70 63.65 147.25
IPCALAB 1953.30 56.72 329.23
LAURUSLABS 1970.00 20.74 102.57
LALPATHLAB 1838.20 39.68 157.23
PFIZER 3612.30 170.54 963.41
AJANTPHARM 3283.90 89.3 363.23
SANOFI 2772.80 158.05 332.96
NATCOPHARM 791.85 82.14 505
APLLTD 760.10 48.4 295.69
JBCHEPHARM 2408.90 54.16 251.48
GLENMARK 2166.60 1.24 881.78
AAREYDRUGS 106.73 2.39 53.38
JUBLPHARMA 938.30 4.35 145.63
SPARC 171.77 48.14 40.45
GRANULES 794.75 23.25 180.42
ASTRAZEN 5988.50 86.44 364.29
CAPLIPOINT 2222.00 55.52 285.6
FDC 338.70 21.19 161.21
HIKAL 193.65 9.34 96.63
Updated at: 2026-10-23 15:31:09

Feel free to contact us, in case of any queries.

Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2477.00 -73.00 (-2.86%) | ADANIPORTS 1702.70 -47.30 (-2.7%) | APOLLOHOSP 7730.00 125.50 (1.65%) | ASIANPAINT 2307.00 22.20 (0.97%) | AXISBANK 1217.50 5.50 (0.45%) | BAJAJ-AUTO 10072.00 -83.00 (-0.82%) | BAJAJFINSV 1655.00 -23.00 (-1.37%) | BAJFINANCE 928.95 -13.15 (-1.4%) | BEL 362.00 -2.50 (-0.69%) | BHARTIARTL 1892.10 -2.90 (-0.15%) | CIPLA 1338.00 7.10 (0.53%) | COALINDIA 397.45 -5.10 (-1.27%) | DRREDDY 1229.50 -9.50 (-0.77%) | EICHERMOT 7066.00 -18.50 (-0.26%) | GRASIM 2894.00 -0.40 (-0.01%) | HCLTECH 1422.20 0.50 (0.04%) | HDFCBANK 692.80 -1.25 (-0.18%) | HDFCLIFE 523.75 -4.60 (-0.87%) | HINDALCO 869.85 -15.75 (-1.78%) | HINDUNILVR 1814.70 -13.60 (-0.74%) | ICICIBANK 1394.20 -4.30 (-0.31%) | INDIGO 4549.00 -51.00 (-1.11%) | INFY 1153.80 0.45 (0.04%) | ITC 257.90 -1.00 (-0.39%) | JIOFIN 205.03 -5.77 (-2.74%) | JSWSTEEL 1185.50 -34.50 (-2.83%) | KOTAKBANK 430.50 -6.50 (-1.49%) | LT 3647.00 8.70 (0.24%) | M&M 2861.20 -2.90 (-0.1%) | MARUTI 11230.00 60.00 (0.54%) | MAXHEALTH 815.00 -2.00 (-0.24%) | NESTLEIND 1175.00 -14.90 (-1.25%) | NTPC 298.00 -4.60 (-1.52%) | ONGC 227.50 2.50 (1.11%) | POWERGRID 247.40 -1.00 (-0.4%) | RELIANCE 1190.00 5.50 (0.46%) | SBILIFE 1640.00 -2.90 (-0.18%) | SBIN 958.60 -11.40 (-1.18%) | SUNPHARMA 1748.00 -10.00 (-0.57%) | TATACONSUM 963.90 4.10 (0.43%) | TATASTEEL 167.67 -4.66 (-2.7%) | TCS 2530.00 23.10 (0.92%) | TECHM 1790.00 -39.10 (-2.14%) | TITAN 4299.70 -50.30 (-1.16%) | TMPV 264.60 -5.40 (-2%) | TRENT 2727.50 -48.30 (-1.74%) | ULTRACEMCO 11050.00 92.00 (0.84%) | WIPRO 189.84 -0.57 (-0.3%) |
Top